[1]
Lebwohl, M., Murina, A., Han, G. and Jacobson, A. 2023. Brodalumab: 4-Year US Pharmacovigilance Report. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s132. DOI:https://doi.org/10.25251/skin.7.supp.132.